Skip to the page

Data / Form D filings / Ascribe Bioscience Inc.

Ascribe Bioscience Inc.: Form D filings

Ascribe Bioscience Inc., an agriculture company in Ithaca, NY, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on October 15, 2025, reports $15 million sold of a $15.3 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
95 Brown Road, Suite 202, Ithaca, NY, 14850
Phone
(607) 703-9083
Industry
Agriculture
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1882999

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 15, 2025New notice$15,272,656$15,019,027$253,62911Oct 8, 2025sec.gov
Oct 7, 2024New notice$2,150,000$2,150,0005Oct 1, 2024sec.gov
Aug 3, 2022New notice$3,269,986$3,184,996$84,9907Jul 29, 2022sec.gov
Sep 15, 2021New notice$2,500,000$2,500,00012Aug 27, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alex BondarDirector
Fred GruisDirector
Frank SchroederDirector
Jay FarmerExecutive Officer, Director
Kyle WelbornDirector

Every Form D from the week of Oct 13, 2025 · All recent filings in New York · All recent Agriculture filings

Read from SEC EDGAR. Amount sold is what Ascribe Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.